This is an aggregated industry headline. Read the full story at FiercePharma →
Amgen agrees to $74M settlement to resolve investor lawsuit over potential $10.7B tax bill
Amgen has agreed to a $74 million settlement with investors to resolve a lawsuit that alleged the company hid a $10.7 billion tax bill from the public and kept the company's share price artificially high from July of 2020 to April of 2022.
By FiercePharma
· Jul 22, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-k…
The WeekBriefing
Novo Nordisk filed suit against Eli Lilly over GLP‑1 drugs as Anthropic deepened its rare‑disease biotech work…
The WeekSTAT News ↗
Science Corporation announced the European launch of its retinal implant for patients with age-related macular…